Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/10/2002WO2002078744A1 Remedies for psychoneurosis
10/10/2002WO2002078736A2 Antiallergic pharmaceutical composition
10/10/2002WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain
10/10/2002WO2002078727A1 Medicinal and cosmetic use of hop and co-enzyme q10
10/10/2002WO2002078726A1 Proteotoxin neutralizer
10/10/2002WO2002078725A1 Biologically active chloroform fraction of an extract obtained from a mangrove plant salvadora persica l
10/10/2002WO2002078724A1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l.
10/10/2002WO2002078719A1 Antitumor methods and compositions comprising sesquiterpene derivatives
10/10/2002WO2002078718A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002WO2002078716A2 Methylated promoters for intraductal treatment of breast cancer
10/10/2002WO2002078713A1 Remedies for retina and choroid diseases containing steroids as the active ingredient
10/10/2002WO2002078712A1 Remedies for vesical stimulation in association with prostatauxe
10/10/2002WO2002078711A1 Remedies for vesical hyperesthesia
10/10/2002WO2002078710A1 Remedies for vesical hyperactivity
10/10/2002WO2002078709A2 Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections
10/10/2002WO2002078708A1 Hiv inhibiting pyrazinone derivatives
10/10/2002WO2002078707A1 Pyrrolidine sulfonamides
10/10/2002WO2002078706A1 Farnesyl transferase inhibitors in combination with hmg coa reductase inhibitors for the inhibition for the treatment of cancer
10/10/2002WO2002078704A1 Use of cyclopamine in the treatment of psoriasis
10/10/2002WO2002078703A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
10/10/2002WO2002078701A1 Use of pyrazolopyridines as therapeutic compounds
10/10/2002WO2002078700A1 Pyralopyridines, process for their preparation and use as therapteutic compounds
10/10/2002WO2002078699A1 Compounds and methods
10/10/2002WO2002078698A2 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
10/10/2002WO2002078697A1 Compounds and methods
10/10/2002WO2002078696A1 Compounds and methods
10/10/2002WO2002078694A1 Photosensitiser and method for production thereof
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078692A1 Method of treatment
10/10/2002WO2002078691A1 Duloxetine for treatment of hot flashes
10/10/2002WO2002078689A1 Bone metabolism improving agents
10/10/2002WO2002078688A1 Irrigating fluid
10/10/2002WO2002078686A1 Retinyl carbonates in cosmetic and dermatological preparations
10/10/2002WO2002078685A1 Drugs for vascular lesion
10/10/2002WO2002078684A2 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
10/10/2002WO2002078682A2 Estrogen replacement therapy
10/10/2002WO2002078681A2 Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
10/10/2002WO2002078680A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002WO2002078679A2 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors
10/10/2002WO2002078678A2 Methods of treating cancer using cyplastin combined with a dioxolane nucleoside such as troxacitabine
10/10/2002WO2002078677A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002WO2002078676A2 Enteric ketoacid salts and amino acids
10/10/2002WO2002078671A1 Medical aerosol formulations
10/10/2002WO2002078669A1 Medicinal solutions
10/10/2002WO2002078666A1 Metronidazole pledgets
10/10/2002WO2002078648A2 Topical composition comprising an antifungal
10/10/2002WO2002078641A2 Pyrrolidine sulfonamides
10/10/2002WO2002078639A2 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002WO2002078638A2 Morpholino imaging and therapy
10/10/2002WO2002078637A2 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
10/10/2002WO2002078634A2 Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection
10/10/2002WO2002078633A2 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
10/10/2002WO2002078629A2 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
10/10/2002WO2002078627A2 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078624A2 Aerosol administration of interleukin-2 liposomes
10/10/2002WO2002078623A2 Uses of targeted oxidative therapeutic formulation in arteriosclerosis
10/10/2002WO2002078622A2 Targeted oxidative therapeutic formulation
10/10/2002WO2002078620A2 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
10/10/2002WO2002078617A2 Materials and methods for treatment of cancer and identification of anti-cancer compounds
10/10/2002WO2002078616A2 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
10/10/2002WO2002078615A2 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002WO2002078605A2 Premixed amiodarone parenteral solution and method for making the same
10/10/2002WO2002078602A2 Transdermal delivery of pergolide
10/10/2002WO2002078580A1 Condom with an erectogenic composition
10/10/2002WO2002078526A2 Cancer-testis antigens
10/10/2002WO2002078523A2 Agent for the treatment of overactive bladder
10/10/2002WO2002078469A1 Low glycemic response compositions
10/10/2002WO2002078468A1 Food or beverage for vascular disorder or disease
10/10/2002WO2002078464A2 Food item for increasing cognitive capacity
10/10/2002WO2002078458A1 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index
10/10/2002WO2002078446A1 Composition to reduce exercise-induced swelling of joints
10/10/2002WO2002078445A1 Formulations comprising entrapped active ingredients and uses thereof
10/10/2002WO2002078444A1 Anticancer and chemopreventative agents and methods of use thereof
10/10/2002WO2002072809A8 Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity
10/10/2002WO2002072086A8 Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
10/10/2002WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002WO2002062795A9 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/10/2002WO2002060422A3 Treatment of diabetes mellitus using vardenafil
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002058636A3 Novel cannabimimetic ligands
10/10/2002WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/10/2002WO2002057215A3 Sodium channel modulators
10/10/2002WO2002053516A3 N(phenylsulphonyl)glycine derivatives and their therapeutic use
10/10/2002WO2002051413A3 Macrocyclic anti-viral compounds
10/10/2002WO2002050067A3 Pharmaceutical heterocyclic compounds
10/10/2002WO2002047725A3 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
10/10/2002WO2002046178A3 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/10/2002WO2002041881A3 Repinotan kit
10/10/2002WO2002041827A3 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
10/10/2002WO2002039983A3 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
10/10/2002WO2002036546A3 Alkynyl amides and their therapeutic applications
10/10/2002WO2002034240A3 Delayed and sustained release formulations and method of use thereof
10/10/2002WO2002034072A3 Synergistic antioxidant combination of delta tocols and polyphenols
10/10/2002WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002WO2002024706A3 Water soluble rapamycin esters
10/10/2002WO2002013809A3 Compositions containing hypotriglyceridemically active stilbenoids
10/10/2002WO2001095895A3 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
10/10/2002WO2001093852A3 Method of treating pain using nalbuphine and opioid antagonists
1 ... 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 ... 7860